NeoGenomics, Inc. (NEO)

NeoGenomics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, NeoGenomics stock has a consensus rating of "Buy" and an average price target of $15.67. The average 1-year stock price forecast is 8.97% higher than the current stock price, while the lowest is $11 (-23.50%) and the highest is $25 (+73.85%).

Price Target: $15.67 (+8.97%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$11	$15.67	$15	$25
Change	-23.50%	+8.97%	+4.31%	+73.85%

Analyst Ratings

The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	4	4	6	6	6	6
Buy	2	2	2	2	2	2
Hold	7	7	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daniel Brennan TD Cowen	TD Cowen	Buy Maintains $14 → $19	Buy	Maintains	$14 → $19	+32.13%	Jul 15, 2026
Michael Ryskin Bank of America Securities	Bank of America Securities	Hold Maintains $11 → $16	Hold	Maintains	$11 → $16	+11.27%	Jul 13, 2026
William Bonello Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jul 9, 2026
Andrew Brackmann William Blair	William Blair	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 27, 2026
Mark Massaro BTIG	BTIG	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

800.44M

Increased by 10.05%

from 727.33M

Revenue Next Year

880.69M

Increased by 10.03%

from 800.44M

EPS This Year

0.18

Increased by 50.00%

from 0.12

EPS Next Year

0.36

Increased by 102.53%

from 0.18

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	484.33M	509.73M	591.64M	660.57M	727.33M	800.44M
Revenue Growth	8.97%	5.24%	16.07%	11.65%	10.11%	10.05%
Gross Profit	187.06M	187.90M	244.60M	290.10M	313.89M	357.49M
Gross Margin	38.62%	36.86%	41.34%	43.92%	43.16%	44.66%
Operating Income	-118.75M	-153.11M	-96.65M	-71.10M	-69.65M	-64.33M
Net Income	-8.35M	-144.25M	-87.97M	-78.73M	-108.03M	-57.81M
EPS	-	-	-	-	0.12	0.18
EPS Growth	-	-	-	-	9.09%	50.00%
Forward PE	266.98	266.98	266.98	103.91	83.58	79.89
Free Cash Flow	-64.72M	-30.50M	-272.88K	-1.93M	17.20M	23.01M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	802.7M
Avg	800.4M
Low	798.8M

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.4%
Avg	10.1%
Low	9.8%

EPS Forecast

EPS	2026	2027	2028
High	0.27
Avg	0.18
Low	0.14

EPS Growth

EPS Growth	2026	2027	2028
High	125.0%
Avg	50.0%
Low	16.7%

Data Sources: S&P Global Market Intelligence and TipRanks Last updated: Jul 15, 2026

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Individual analyst data is provided by TipRanks. Price targets and consensus ratings update every hour to every three days, while individual analyst data updates in near real-time.

Last checked:

Jul 15, 2026

Data Sources Report a data error